Assuntos
Compostos Benzidrílicos/uso terapêutico , Cresóis/uso terapêutico , Antagonistas Muscarínicos/uso terapêutico , Fenilpropanolamina , Incontinência Urinária/tratamento farmacológico , Compostos Benzidrílicos/metabolismo , Cresóis/metabolismo , Humanos , Antagonistas Muscarínicos/metabolismo , Tartarato de TolterodinaAssuntos
Antidepressivos de Segunda Geração/uso terapêutico , Estimulantes do Sistema Nervoso Central/uso terapêutico , Cicloexanóis/uso terapêutico , Transtorno Depressivo/tratamento farmacológico , Metilfenidato/uso terapêutico , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Idoso , Quimioterapia Combinada , Humanos , Masculino , Cloridrato de VenlafaxinaRESUMO
BACKGROUND: Our investigation involved a quantitative literature review technique known as meta-analysis to compare the efficacy of three newer antidepressants and imipramine. METHOD: We examined seven major journals in psychiatry from 1980 through 1990, inclusive, and selected those investigations of imipramine, trazodone, bupropion, and fluoxetine that met our minimal criteria for interpretability. These criteria included: (1) the presence of a placebo control, (2) double-blind status, (3) the use of the Hamilton Rating Scale for Depression as a dependent variable measure, (4) the use of nongeriatric adults with a diagnosis of major depression by DSM or RDC standards, and (5) the presence of reported means and standard deviations in the investigation, or sufficient data that allowed such to be computed. Each study of four antidepressants was analyzed for an effect size of the drug investigated. The effect size allows for a determination of the efficacy of a particular drug as compared with placebo, measured in standard deviation units. RESULTS: The data indicated that all four agents are effective as compared with placebo. Furthermore, there is no evidence that the newer heterocyclic agents are less effective than imipramine, as an ANOVA showed no statistically significant difference between the effect sizes of the four antidepressants. CONCLUSION: These data are discussed in terms of characteristics of the various investigations and the need for further research comparing the efficacy of psychopharmacologic agents.
Assuntos
Antidepressivos/uso terapêutico , Transtorno Depressivo/tratamento farmacológico , Imipramina/uso terapêutico , Bupropiona/uso terapêutico , Transtorno Depressivo/psicologia , Fluoxetina/uso terapêutico , Humanos , Trazodona/uso terapêuticoRESUMO
The microcomputer provides a powerful tool for managing a wide variety of clinical data. With database management software, information can be stored in random fashion, rearranged in a number of more useful sequences, and retrieved according to various criteria specified by the user. Most database software permits calculations on numeric data, report generation, and the ability to transfer data to and from both spread-sheet and word-processing software.